Revenue decreased 9.1%
Revenue changed -9.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue changed -9.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
SBC / revenue changed +322 basis points from the comparable as-filed period.
Stock-based compensation changed +56.0% from the comparable as-filed period.
Operating cash flow / net income changed +730.0% from the comparable as-filed period.
Operating cash-flow margin changed +2221 basis points from the comparable as-filed period.
Capital expenditure changed +211.4% from the comparable as-filed period.
Free-cash-flow margin changed +2142 basis points from the comparable as-filed period.
Capex / revenue changed +79 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Stockholders' equity changed +7.7% from the comparable as-filed period.
Total assets changed +7.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Cash & equivalents changed -0.7% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.